RHJA
EW icon

Rice Hall James & Associates’s Edwards Lifesciences EW Stock Holding History

Rice Hall James & Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522K Sell
6,514
-67
-1% -$5.52K 0.03% 223
2025
Q4 		$561K Sell
6,581
-11
-0.2% -$903 0.03% 216
2025
Q3 		$513K Sell
6,592
-36
-0.5% -$2.81K 0.03% 223
2025
Q2 		$518K Sell
6,628
-37
-0.6% -$2.76K 0.03% 218
2025
Q1 		$483K Buy
6,665
+112
+2% +$8.02K 0.03% 220
2024
Q4 		$485K Sell
6,553
-2
-0% -$140 0.03% 230
2024
Q3 		$433K Sell
6,555
-150
-2% -$10.9K 0.02% 234
2024
Q2 		$619K Sell
6,705
-113
-2% -$10K 0.04% 221
2024
Q1 		$652K Sell
6,818
-4,831
-41% -$406K 0.04% 223
2023
Q4 		$888K Hold
11,649
– – 0.05% 221
2023
Q3 		$807K Hold
11,649
– – 0.05% 219
2023
Q2 		$1.1M Sell
11,649
-8,128
-41% -$706K 0.06% 212
2023
Q1 		$1.64M Sell
19,777
-219
-1% -$17.2K 0.09% 209
2022
Q4 		$1.49M Sell
19,996
-4,224
-17% -$326K 0.09% 217
2022
Q3 		$2M Sell
24,220
-3,682
-13% -$354K 0.12% 186
2022
Q2 		$2.65M Sell
27,902
-977
-3% -$101K 0.13% 163
2022
Q1 		$3.4M Sell
28,879
-651
-2% -$73K 0.14% 152
2021
Q4 		$3.83M Sell
29,530
-22
-0.1% -$2.57K 0.14% 148
2021
Q3 		$3.35M Sell
29,552
-959
-3% -$109K 0.12% 129
2021
Q2 		$3.16M Sell
30,511
-2,155
-7% -$203K 0.11% 138
2021
Q1 		$2.73M Sell
32,666
-2,323
-7% -$196K 0.09% 157
2020
Q4 		$3.19M Sell
34,989
-6,501
-16% -$539K 0.11% 135
2020
Q3 		$3.31M Sell
41,490
-2,997
-7% -$234K 0.13% 123
2020
Q2 		$3.07M Sell
44,487
-843
-2% -$59.9K 0.13% 124
2020
Q1 		$2.85M Sell
45,330
-11,025
-20% -$795K 0.16% 124
2019
Q4 		$4.38M Sell
56,355
-384
-0.7% -$30K 0.15% 123
2019
Q3 		$4.16M Sell
56,739
-4,038
-7% -$284K 0.15% 123
2019
Q2 		$3.74M Sell
60,777
-687
-1% -$41.5K 0.12% 129
2019
Q1 		$3.92M Sell
61,464
-1,278
-2% -$72.9K 0.13% 136
2018
Q4 		$3.2M Sell
62,742
-255
-0.4% -$12.9K 0.12% 132
2018
Q3 		$3.66M Sell
62,997
-369
-0.6% -$18K 0.13% 130
2018
Q2 		$3.08M Sell
63,366
-1,338
-2% -$62.5K 0.11% 138
2018
Q1 		$3.01M Sell
64,704
-420
-0.6% -$18.2K 0.12% 130
2017
Q4 		$2.45M Sell
65,124
-8,286
-11% -$304K 0.1% 168
2017
Q3 		$2.67M Hold
73,410
– – 0.12% 147
2017
Q2 		$2.89M Sell
73,410
-29,664
-29% -$1.08M 0.13% 121
2017
Q1 		$3.23M Sell
103,074
-14,841
-13% -$465K 0.16% 112
2016
Q4 		$3.68M Buy
117,915
+59,898
+103% +$1.94M 0.19% 106
2016
Q3 		$2.33M Sell
58,017
-1,620
-3% -$61K 0.12% 155
2016
Q2 		$1.98M Sell
59,637
-3,021
-5% -$103K 0.11% 177
2016
Q1 		$1.84M Sell
62,658
-6,111
-9% -$169K 0.11% 183
2015
Q4 		$1.81M Sell
68,769
-84,231
-55% -$2.19M 0.1% 185
2015
Q3 		$3.63M Sell
153,000
-4,020
-3% -$97K 0.23% 97
2015
Q2 		$3.73M Sell
157,020
-16,806
-10% -$379K 0.22% 105
2015
Q1 		$4.13M Buy
173,826
+2,160
+1% +$48.5K 0.24% 105
2014
Q4 		$3.64M Sell
171,666
-78,342
-31% -$1.57M 0.22% 114
2014
Q3 		$4.26M Sell
250,008
-588
-0.2% -$9.28K 0.3% 78
2014
Q2 		$3.58M Buy
+250,596
New +$3.4M 0.24% 86

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Rice Hall James & Associates's EW Position: Q1 2026 in Review

Rice Hall James & Associates reduced its Edwards Lifesciences (EW) stake by 1% in Q1 2026, selling an estimated $5.52K and leaving 6,514 shares worth $522K. The position accounts for 0.03% of the portfolio, ranked #223.

Rice Hall James & Associates first reported a position in EW in Q2 2014 and has held it in 48 quarters since. The position peaked at $4.38M in Q4 2019. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Rice Hall James & Associates held 6,514 shares of Edwards Lifesciences worth $522K as of Q1 2026.
  • Rice Hall James & Associates sold 67 Edwards Lifesciences shares in Q1 2026, an estimated $5.52K.
  • Edwards Lifesciences made up 0.03% of Rice Hall James & Associates's portfolio in Q1 2026, its #223 holding.
  • Rice Hall James & Associates first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 48 quarters since.
  • Rice Hall James & Associates's Edwards Lifesciences position peaked at $4.38M in Q4 2019.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.